China Pharmaceutical University Pharmaceutical

China Pharmaceutical University Pharmaceutical is a state-owned pharmaceutical enterprise affiliated with China Pharmaceutical University, one of China's leading academic institutions for pharmacy. Established in 1958, the company serves as a critical bridge between academic research and industrial production, focusing on the development, manufacturing, and commercialization of a wide range of pharmaceutical products. Its portfolio includes chemical drugs, traditional Chinese medicines, and health supplements, with a strong emphasis on cardiovascular and metabolic health. The company is particularly recognized for its long-standing presence in the hypertension market with its flagship compound formulations. Leveraging the university's extensive R&D resources, it maintains high standards in quality control and technological innovation across various dosage forms.